美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immune Design

5.85

0.0000

成交量：- -

成交額：- -

市值：2.83億

市盈率：-5.14

高：5.85

開：5.85

低：5.85

收：5.85

52周最高：5.85

52周最低：1.10

股本：4,836.52萬

流通股本：3,047.57萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.1373

每股收益(LYR):-1.1373

淨資產收益率：--

總資產收益率：--

市淨率：3.08

市盈率(LYR):-5.14

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Immune Design

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.immunedesign.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Immune Design Corp.於2008年2月在特拉華州成立。公司是一家與新一代的體內設計療法使人體的免疫系統足夠抵抗疾病。公司已經設計了技術來激活創建腫瘤特異性細胞毒性T細胞來對抗癌症的免疫系統的天然能力。公司從其發現的兩個平台DCVexTM and GLAASTM中開發了多個候選產品，這些產品是公司認為其有治療廣泛患者的潛力。公司的候選產品lv305，cmb305與G100能夠利用多種免疫治療方法解決現有的治療方法的缺點。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IMDZ/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMDZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDZ\",,,,,undefined,":{"symbol":"IMDZ","market":"US","secType":"STK","nameCN":"Immune Design","latestPrice":5.85,"timestamp":1557432000000,"preClose":5.85,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":30475702,"shares":48365248,"eps":-1.13735,"marketStatus":"停牌","change":0,"latestTime":"02-24 12:13:18 EST","open":5.85,"high":5.85,"low":5.85,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.13735,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1406174400000,"exchange":"NASDAQ","adjPreClose":5.85,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDZ\",,,,,undefined,":{"symbol":"IMDZ","floatShares":30475702,"roa":"--","roe":"--","lyrEps":-1.13735,"shares":48365248,"dividePrice":0,"high":5.85,"amplitude":0,"preClose":5.85,"low":5.85,"week52Low":1.1,"pbRate":"3.08","week52High":5.85,"institutionHeld":0,"latestPrice":5.85,"eps":-1.13735,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.13735,"open":5.85,"prevYearClose":5.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-06","symbol":"IMDZ","fiscalQuarterEnding":"2018/09","expectedEps":-0.32,"name":null,"time":"盤後","type":"earning","dateTimestamp":1541480400000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2018-08-01","symbol":"IMDZ","fiscalQuarterEnding":"2018/06","expectedEps":-0.3,"name":null,"time":"","type":"earning","dateTimestamp":1533096000000,"reportTimeType":"","actualEps":-0.29},{"market":"US","date":"2018-05-02","symbol":"IMDZ","fiscalQuarterEnding":"2018/03","expectedEps":-0.29,"name":null,"time":"盤後","type":"earning","dateTimestamp":1525233600000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2018-03-14","symbol":"IMDZ","fiscalQuarterEnding":"2017/12","expectedEps":-0.39,"name":null,"time":"盤後","type":"earning","dateTimestamp":1521000000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2017-11-01","symbol":"IMDZ","fiscalQuarterEnding":"2017/09","expectedEps":-0.63,"name":null,"time":"盤後","type":"earning","dateTimestamp":1509508800000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.immunedesign.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Immune Design Corp.於2008年2月在特拉華州成立。公司是一家與新一代的體內設計療法使人體的免疫系統足夠抵抗疾病。公司已經設計了技術來激活創建腫瘤特異性細胞毒性T細胞來對抗癌症的免疫系統的天然能力。公司從其發現的兩個平台DCVexTM and GLAASTM中開發了多個候選產品，這些產品是公司認為其有治療廣泛患者的潛力。公司的候選產品lv305，cmb305與G100能夠利用多種免疫治療方法解決現有的治療方法的缺點。","exchange":"NASDAQ","name":"Immune Design","nameEN":"Immune Design"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMDZ\",market:\"US\",,,undefined,":null}}